Aspacardin

Aspacardin is a well-established pharmaceutical supplement primarily used in the Romanian market to support heart health and treat magnesium and potassium deficiencies. It is specifically formulated to help manage electrolyte imbalances that can lead to cardiac rhythm disorders.

The brand has its roots in Romania, specifically through Terapia, which has been a pillar of the Romanian pharmaceutical industry since its founding in 1921. Over the decades, the product has become a staple in local households for cardiovascular maintenance.

Today, the brand is owned by Sun Pharmaceutical Industries Ltd., a global pharmaceutical giant headquartered in India. Following Sun Pharma acquisition of Ranbaxy (which had previously acquired Terapia), Aspacardin remains a key product in their portfolio, manufactured locally in Romania to serve the European market while benefiting from the global R&D and supply chain infrastructure of its Indian parent company.